BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SSGJ-706 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SSGJ-706\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07233850-2740@assetmemo.bio
DTSTAMP:20261121T005651Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:SSGJ-706: Phase 2 readout est. (NCT07233850)
DESCRIPTION:SSGJ-706\, phase 2.\nStudy: A Phase II Clinical Study Evaluatin
 g SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers\nE
 stimated primary completion: December 2026. This is a ClinicalTrials.gov e
 stimate\, not a confirmed readout date\, and it can move.\nDrug page: http
 s://assetmemo.bio/drug/ssgj-706#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07233850
URL:https://assetmemo.bio/drug/ssgj-706#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07874984-2740@assetmemo.bio
DTSTAMP:20261121T005651Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:SSGJ-706: Phase 2 readout est. (NCT07874984)
DESCRIPTION:SSGJ-706\, phase 2\, Non-Small Cell Lung Cancer.\nStudy: SPGL00
 8 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell
  Lung Cancer\nEstimated primary completion: November 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/ssgj-706#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07874984
URL:https://assetmemo.bio/drug/ssgj-706#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
